Comera Life Sciences Announces Expansion of Patent Portfolio Underlying Core Excipient Technology
– Notice of Allowance of U.S. patent application received for expansion of core viscosity reduction claims for excipients in SQore™ platform – – Patent granted in South... | April 3, 2023
Source: marketscreener.com